-+ 0.00%
-+ 0.00%
-+ 0.00%
According to Cardiac Healthcare, recently, the Fishhawk® /Osprey® disposable thrombectomy device developed by Blue Vein Medical®, a subsidiary of Cardiac Healthcare, began the first batch of clinical applications after marketing in various hospitals including Shanghai Ninth People's Hospital, Huashan Hospital affiliated to Fudan University, and Guangdong Provincial Hospital of Traditional Chinese Medicine. This product is one of the key innovative products launched by Cardiovascular Medicine in the field of peripheral venous intervention. It uses innovative thrombolization principles, isolation technology and integrated portable design to bring new clinical treatment options for percutaneous intradermal excision of acute venous thrombosis and deep femoral vein thrombosis.
Share
Listen to the news
According to Cardiac Healthcare, recently, the Fishhawk® /Osprey® disposable thrombectomy device developed by Blue Vein Medical®, a subsidiary of Cardiac Healthcare, began the first batch of clinical applications after marketing in various hospitals including Shanghai Ninth People's Hospital, Huashan Hospital affiliated to Fudan University, and Guangdong Provincial Hospital of Traditional Chinese Medicine. This product is one of the key innovative products launched by Cardiovascular Medicine in the field of peripheral venous intervention. It uses innovative thrombolization principles, isolation technology and integrated portable design to bring new clinical treatment options for percutaneous intradermal excision of acute venous thrombosis and deep femoral vein thrombosis.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending